Document 7OXjM5jj3OLjDZDxKO6j4p3RV

PN *4*. 1 The Cosmetic, Toiletry and Fragrance Association, Inc. 1133 15th STREET; N.W., WASHINGTON, D.C. 2005 * 202/331-1770 * TELEX 89-2673 James H. Merritt PriMxit Norman P, Estrin. Ph D. We t r w i ii t n t ^ P rtn tt & IN-PTE S CTFA TALC TASK FORCE A meeting of -the CTFA Talc Task- Force was held on March IIth, 1976 at th CTFA offices in Washington, D.C. Those in attendance were! George Sandland, Bristol-Myers company (Chairman) John.E* lments, 'Pfizer*. *ic. Ray/Rrammer, Whittaker C-Iark- & Daniels George, Lee, Johnson & Johnson Baby products Company Monroe- Messing,er, Chesebrough-Pgnd*.s Inc.' "'.Roderick A '.Muhdy,' Sterling'Drug Inc. Louis D . Murino,, Cyprus Industrial Minerals .Company *-D.Ri'Patterson, Johnson & Johnson Baby Products Company Fred Rpesch,- Whittaker, Clairk & Daniels ' Robert Rolle, Johnson & -Johnson Baby Products Ccmpany Johh .P. Sheiz> -Johfisn $ 'Johnson Baby Products Company Maurice Riegei, Pbrge, inc, J,C. .Simkoy jr>, oigt-Palmol ive;Company Baroid; Stanley, Pfizer,' Inc ' Tan RtewartJ' Walter C* Mcrone Associates. Robert Suffis, The Menne'n. Company S. Thompson,. R.Ti Vanderbilt & Company John J. Travers, Avon Products, Inc. William' C, Waggoner, Johnson & Johnson .Baby Products Coraoany Norman F. strin, '.CTFA Hr. Sandland opened the. meeting and proceeded with th 'agenda. {* 1. Status Review A. Tal-p Standards, and -Methods Copies of th- proposed specification and methods, plus copies of a letter to Dr. Schaffner vere distributed to task force members. B. A -status .-report; (dated' March 8thr.1976) , prepared by... Dt Potterson, on cosmetic talc statas was distributed to those prosent.-* a copy of ah article by' CONTINUED ON NEXT PAGE PD Ex. No.:_Jir--- - Deponent: Date Shirley Q. C,asiila. n' , rC^SciR No. 12361 PLAINTIFFS EXHIBIT CAM-51 EXH lBlfQ L_? -i tir. 'Kohl ,a.d Dr., Arthur M. Laager on. "Identification <in Ottantitalln pf Asbtos in ^Taic" was distributed as 'it appears in Bnviforanentai lea1th Perspectives , Volutile 5, 974, pp."95-109. .Also* a copy of the correction t the; March'-8,. 1975 Washington Post -article 6ri talc and the summary; of. t'&e.draft ''ialF'I'a'per anticipated from the FDa was distributed to those present. ' Sx . , * C. lwin.'apeS. .i t ., Mi. Sandahd SurnnfizeU the e`dnteiits"pf the November, 197.5 letter, from Henfy DaVis (FDA) requesting CTFA hpFly its methodology .to several' of Dr. Lewin samples provided on a coded- basisi The results of the analyses were described bv Dir .Bolle. Mt ..'Sinai Analyses -bnOld .Production Cantles Dr** Betterson, fave-'detailed background -Oh Dt,.hanger *s work. HP`stated the objective of -the .task.force should he to de velop pd ,collate data that would ..lead fcp presentatoa befte, the*Miscellaneous 'External Panel,'.in.*order to attempt to have' talc placed in Category I. ;%he results of or* Pooleyf3 .analyses,. .sponsored .by Johnson s Johnson,, were summarized. .It "|?as reported.that Dr. lancer performed-his anarises on sam ples' purchased 'in 197.3, %t. Simlco'dscribed a meeting .between himself and .Dr, Lancer >oh._Tuesday. He estimated the sample of "Cashmere Boucmt" ts-d was probably a..pr-19?0 samle. . Mr*-Mundy {Sterling} reported -on-his contacts with 'Dr. Laager and stated the Sample D. Lander tested was from 1970 production. Becent Production Data it was agreed by the,task Force that ,,it*.;would be extremo)y beneficial if Induidual Companies, could provide' data to 'the FDA'.On ..recent production.,/Most companies present indicated that*they posss such data, and would be willing to -provide the data.*..Mrs Messihger '(c^^ro^h'-Pbd*s) stated he would have' to confina this willingness with his management. It. was -suggested eachtcoppahy `prepare a *letter,, addressed to Dr. Esjtrin, With- a summary of*the data oh recent-production for .:th#ir4products and' a commitment -to set-up. a subsequent meeting with FDA* to -discuss this data, in detail, if FDA so desires... This..letter .should be delivered to Dr, Estrtn by Monday, 'March |Sth, Subsequently, a meeting was set-up for that Monday, March 15th, At* the CTFA offices, with-a meeting at FDA. to-joe held in. ;the -Afternoon.\. ClFA Study on Current. Production- Advantages '&$$ disadvantages*of haying CTFA contract an in dependent laboratory*.to do tests on current proludici sam ples -was discussed,* It was' noted that such data Would no * dou-t be useful,- hot-only in discussions with FDA,"but -Iso part of a presentation to the Miscellaneous External Pane) And,, perhaps, to other 'panels as well-t it was suggested the CTFA methodology be utilized for such-a task, but., that TEM be Used on those samples that have been 'shown to be positive CONTINFED ON NEXT PACE BcsT # .i m in # ; pRObori 1338 1339 1340 1341 13.42 1343 1344 1345 1346 1347 1348 1349 13 50 1351 1352 7-? .77 96 97 101 102A 143 144B 151 154 15 7A 160 163 75 17 3A .Lady Ester Face Powder, Rachel Touch and Glow Face Powder Blanchard's Dusting Powder Born Wild Dusting Powder, Del Labs Tai Winds Spray Talc, Avon Tosca Dusting Powder Pin-Zow Talque, Perf. Beauty Prod. Overton's ."High Brown" Face Powder Early American Old Spice Talcum Powder B i s m o l i R e Hedi.ea.ted P o w d e r Havis. Imported Talcum Avon Beauty. Dust Refill - Charisma Pinaud Clubman Talc QH1 de .London Tate, Yardley Corsage Dusting Powder TftEKim ' .. ' M H iT ^ W s t ... i e h TCHFR"Y"1SOTtlOU t X-M ,, ,(QH) .... .i< * ~ m ND 3 8 T U 15 10 5 5 ND 2 6 Ni) 10 ND ND 2,800 f/mg. ND 5,800 ND 13,000 10 60,000 15 8,900 ND 1,800 7 400 10 ND ? 2,000 ND 9,000 ND ND 8 9 000 traces ? 10 ND ND ? ND ? * ND ND ND - ND - ND ND - ? ? by CTPA methodology and aiso be performed on a random basis on other `samjjl.es,,', Company representatives were polled at this meeting and''previously by Mr. George Lee to determine whether they would- be;willing to, participate in such a study .by assur ing-that current production samples -would be provided and that financial support,would be'given. The results would be made kn^wn-'to the 'F0A add, pbobably published'in some form. The foilgwiftg eompariies indicated they would be willing to partidipath: Avon.Products', Inc. Bristol-Myers Company Colgate-Palmolive Company Coty, 'inc. Faberge. Inc. Qhnsoh & Johnson Mermen Sterling , *. In addition, Chesebrough-Pond's, Mem,' and Yard ley would probably be. interested. The- task force -agreed to await the results of the meetinas. with CTFA before deciding on whether a study on current produc tion should be initiated. The meeting djburned in order for a .small group to meet with-FDA at 2:00 p.m. to discuss the results of CTFA analyses of Dr. Lewin's samples, I Estrin, Ph.'D, Vice President - Science NFEi.jj March 12th, 1976 ./ * _g_ 'wWfll